Pfizer's blood cancer drug Bosulif effective in untreated patients
December 05, 2016 at 08:43 AM EST
Dec 5 (Reuters) - Pfizer Inc said on Monday its cancer drug, Bosulif, was found effective in a late-stage study on previously untreated patients with a form of blood and bone marrow cancer that is characterized by the abnormal production of white blood cells.